Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma

SIMPLE SUMMARY: T-cell lymphoblastic lymphoma (T-LBL) is a rare and aggressive lymphatic cancer, most often diagnosed in teenagers and young adults. Nowadays, patients are treated with chemotherapy or undergo a hematopoietic stem cell transplantation. This can cause many short- and long-term side-ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Provez, Lien, Putteman, Tom, Landfors, Mattias, Roels, Juliette, Reunes, Lindy, T’Sas, Sara, Van Loocke, Wouter, Lintermans, Béatrice, De Coninck, Stien, Thenoz, Morgan, Sleeckx, Wouter, Maćkowska-Maślak, Natalia, Taghon, Tom, Mansour, Marc R., Farah, Nadine, Norga, Koen, Vandenberghe, Peter, Kotecha, Rishi S., Goossens, Steven, Degerman, Sofie, De Smedt, Renate, Van Vlierberghe, Pieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913791/
https://www.ncbi.nlm.nih.gov/pubmed/36765607
http://dx.doi.org/10.3390/cancers15030647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913791/
https://www.ncbi.nlm.nih.gov/pubmed/36765607
http://dx.doi.org/10.3390/cancers15030647

Ejemplares similares